{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:14:38Z","timestamp":1769602478763,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":7251,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1008340723974","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"307-314","source":"Crossref","is-referenced-by-count":77,"title":["Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome"],"prefix":"10.1016","volume":"11","author":[{"given":"W.D.","family":"Foulkes","sequence":"first","affiliation":[]},{"given":"P.O.","family":"Chappuis","sequence":"additional","affiliation":[]},{"given":"N.","family":"Wong","sequence":"additional","affiliation":[]},{"given":"J.-S.","family":"Brunet","sequence":"additional","affiliation":[]},{"given":"D.","family":"Vesprini","sequence":"additional","affiliation":[]},{"given":"F.","family":"Rozen","sequence":"additional","affiliation":[]},{"given":"Z.Q.","family":"Yuan","sequence":"additional","affiliation":[]},{"given":"M.N.","family":"Pollak","sequence":"additional","affiliation":[]},{"given":"G.","family":"Kuperstein","sequence":"additional","affiliation":[]},{"given":"S.A.","family":"Narod","sequence":"additional","affiliation":[]},{"given":"L.R.","family":"B\u00b4gin","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1023\/A:1008340723974_bb0100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJM199206253262607","article-title":"Prognostic factors and treatment decisions in axillary-node-negative breast cancer","volume":"326","author":"McGuire","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008340723974_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3322\/canjclin.47.1.28","article-title":"Tumor-related prognostic factors for breast cancer","volume":"47","author":"Donegan","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1023\/A:1008340723974_bb0110","first-page":"35","article-title":"Breast cancer outcome and predictors of outcome: are there age differentials?","volume":"16","author":"Albain","year":"1994","journal-title":"Monogr Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0115","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1023\/A:1008301314812","article-title":"The influence of familial and hereditary factors on the prognosis of breast cancer","volume":"10","author":"Chappuis","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008340723974_bb0120","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1200\/JCO.1999.17.11.3653","article-title":"Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?","volume":"17","author":"Phillips","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0125","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.1998.16.5.1969","article-title":"BRCA1 and BRCA2: From molecular genetics to clinical medicine","volume":"16","author":"Blackwood","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: A population-based study from Southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumor characteristics of breast-cancer patients with germline mutations of BRCA1","volume":"351","author":"Verhoog","year":"1998","journal-title":"Lancet"},{"key":"10.1023\/A:1008340723974_bb0140","first-page":"2465","article-title":"Germ-Line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0145","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"Robson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0150","series-title":"Lancet","article-title":"Survival in early-onset BRCA1 breast-cancer patients","author":"Ansquer","year":"1998"},{"key":"10.1023\/A:1008340723974_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(98)00023-1","article-title":"Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations","volume":"47","author":"Gaffney","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1023\/A:1008340723974_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1998.16.1.115","article-title":"Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations","volume":"16","author":"Garcia-Patino","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.0.CO;2-N","article-title":"BRCA1-related breast cancer in Austrian breast and ovarian cancer families \u2013 specific BRCA1 mutations and pathological characteristics","volume":"77","author":"Wagner","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008340723974_bb0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","article-title":"Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"91","author":"Lee","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0175","first-page":"1222","article-title":"Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations","volume":"57","author":"Tirkkonen","year":"1997","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0180","first-page":"349","article-title":"BRCAl-p53 relationship in hereditary breast cancer","volume":"10","author":"Sobol","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1023\/A:1008340723974_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/BC.1999.019","article-title":"The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins","volume":"380","author":"Irminger- Finger","year":"1999","journal-title":"Biol Chem"},{"key":"10.1023\/A:1008340723974_bb0190","first-page":"1","article-title":"Mammary tumor formation in p53- and BRCA1-deficient mice","volume":"10","author":"Cressman","year":"1999","journal-title":"Cell Growth Diff"},{"key":"10.1023\/A:1008340723974_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/8743","article-title":"Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation","volume":"22","author":"Xu","year":"1999","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008340723974_bb0200","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.onc.1202106","article-title":"p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1-and BRCA2-associated breast tumours","volume":"17","author":"Crook","year":"1998","journal-title":"Oncogene"},{"key":"10.1023\/A:1008340723974_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/91.5.469","article-title":"Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations","volume":"91","author":"Phillips","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0210","first-page":"859","article-title":"BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability","volume":"58","author":"Gretarsdottir","year":"1998","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0215","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0220","series-title":"Lancet","article-title":"p53 mutations in BRCA1-associated familial breast cancer","author":"Schlichtholz","year":"1998"},{"key":"10.1023\/A:1008340723974_bb0225","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nm1196-1179","article-title":"Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families","volume":"2","author":"Tonin","year":"1996","journal-title":"Nature Med"},{"key":"10.1023\/A:1008340723974_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008340723974_bb0235","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 and BRCA2 mutations and sporadic cases","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1023\/A:1008340723974_bb0240","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0245","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer","volume":"91","author":"Warner","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0250","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast cancers in Ashkenazi Jewish women","volume":"80","author":"Karp","year":"1997","journal-title":"Cancer"},{"key":"10.1023\/A:1008340723974_bb0255","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.bjc.6690775","article-title":"The effect of the 11307K APC polymorphism on the clinicopathological features and natural history of breast cancer","volume":"81","author":"Yuan","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008340723974_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/26.1.205","article-title":"IARC Database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools","volume":"26","author":"Hainaut","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1023\/A:1008340723974_bb0265","first-page":"1","article-title":"Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1023\/A:1008340723974_bb0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005824216444","article-title":"Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?","volume":"47","author":"Degeorges","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1023\/A:1008340723974_bb0275","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1998.16.2.470","article-title":"p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer","volume":"16","author":"Clahsen","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008340723974_bb0280","first-page":"1839","article-title":"BRCA-associated breast cancer: Absence of a characteristic immunophenotype","volume":"58","author":"Robson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0285","first-page":"471","article-title":"Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer","volume":"56","author":"Eisinger","year":"1996","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008340723974_bb0290","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/84.11.845","article-title":"Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers","volume":"84","author":"Thor","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008340723974_bb0295","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(05)63327-2","article-title":"p53 mutations in BRCA1-associated familial breast cancer","volume":"350","author":"Crook","year":"1997","journal-title":"Lancet"},{"key":"10.1023\/A:1008340723974_bb0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0959-437X(98)80056-7","article-title":"Functions of the BRCA1 and BRCA2 genes","volume":"8","author":"Bertwistle","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"10.1023\/A:1008340723974_bb0305","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3+<543::AID-CNCR4>3.0.CO;2-A","article-title":"BRCA1 and BRCA2 hereditary breast carcinoma phenotypes","volume":"80","author":"Marcus","year":"1997","journal-title":"Cancer"},{"key":"10.1023\/A:1008340723974_bb0310","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/bjs.1800811038","article-title":"Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21","volume":"81","author":"Porter","year":"1994","journal-title":"Br J Surg"},{"key":"10.1023\/A:1008340723974_bb0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008340723974_bb0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng1096-188","article-title":"The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 percent","volume":"14","author":"Oddoux","year":"1996","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008340723974_bb0325","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/302099","article-title":"Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families","volume":"63","author":"Tonin","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1023\/A:1008340723974_bb0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008340723974_bb0335","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","article-title":"Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations","volume":"91","author":"Robson","year":"1999","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420315246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/3\/307\/19478318\/11-3-307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:38:56Z","timestamp":1582184336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420315246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0923753420315246"],"URL":"https:\/\/doi.org\/10.1023\/a:1008340723974","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}